A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer

Lung Cancer

Volumn 36, Issue 1, 2002, Pages 105-111

  Atagi, Shinji ^a   Kawahara, Masaaki ^a   Hosoe, Shigeto ^a   Ogawara, Mitsumasa ^a   Kawaguchi, Tomoya ^a   Okishio, Kyoichi ^a   Naka, Nobuyuki ^a   Sunami, Toshihiko ^a   Mitsuoka, Shigeki ^a   Akira, Masanori ^a  

^a NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

Author keywords

Combined modality; Non small cell lung cancer; Radiation therapy

Indexed keywords

CISPLATIN; MITOMYCIN; VINDESINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; ESOPHAGITIS; FEASIBILITY STUDY; FEMALE; GRANULOCYTOPENIA; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0036124954     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00460-3     Document Type: Article

References (28)

1. Improved survival of patients with unresectable non- small cell bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach
2. Long term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group
3. Radiotherapy in the management of locally advanced lung cancer of all cell types: Final report of a randomized trial
4. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer
5. Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: A randomized trial
6. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study
7. Thoracic radiation therapy dose not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer
8. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients
9. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
10. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer
11. Chemoradiation for locally advanced, unresectable NSCLC
12. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stage IIIa and IIIb nonsmall cell lung cancer. A meta-analysis
13. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis
14. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer
15. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer
16. Impact of tumor control on survival in carcinoma of the lung treated with irradiation
17. A new international classification system for lung cancer
18. Optimal two-stage designs for phase II clinical trials
19. Non parametric estimation for incomplete observations
20. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group
21. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: A Hoosier Oncology Group protocol
22. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer
23. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: A California cancer consortium phase II trial
24. Phase II trial of daily low-dose carboplatin and thoracic radiotherapy in elderly patients with locally advanced non-small cell lung cancer
25. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
26. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens
27. Prolonged survival in pathologic stage IIIB non-small cell lung cancer (NSCLC) with concurrent chemoradiotherapy followed by consolidation docetaxel: A phase II study (S9504) of the Southwest Oncology Group (SWOG)